Immunocore Hldgs (NASDAQ:IMCR) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $(0.35) by 148.57 percent. This is a 750 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $80.25 million which missed the analyst consensus estimate of $80.60 million by 0.43 percent. This is a 23.74 percent increase over sales of $64.85 million the same period last year.